Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
A Standard patent application filed on 27 November 2002 credited to Yang, Charles Renkin
;
Bymaster, Franklin Porter
;
Gehlert, Donald Richard
;
Mckinzie, David Lee
Details
Application number :
2002352625
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure
Inventor :
Yang, Charles Renkin
;
Bymaster, Franklin Porter
;
Gehlert, Donald Richard
;
Mckinzie, David Lee
Agent name :
Spruson & Ferguson
Address for service :
Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia
Filing date :
27 November 2002
Associated companies :
Applicant name :
Eli Lilly and Company
Applicant address :
Lilly Corporate Center Indianapolis IN 46285 United States of America